Arkolith/Insider Trading/CRVS/Form 4

Miller Richard A MD

President and CEO, DirectorCorvus Pharmaceuticals, Inc. (CRVS) · full profile →Form 4 · filed Sep 20, 2022
Net Buying
Open-Market Buys
$16K
Open-Market Sells
$0
Net Open-Market Flow
$16K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 20, 2022Buy(P)3K$0.82$2K1.4M
Sep 20, 2022Buy(P)5K$0.82$4K1.4M
Sep 20, 2022Buy(P)12K$0.81$10K1.4M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-22-017639) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML